Mark Nehler
Concepts (389)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ischemia | 28 | 2022 | 374 | 4.450 |
Why?
| Peripheral Arterial Disease | 26 | 2023 | 377 | 4.110 |
Why?
| Internship and Residency | 15 | 2024 | 1001 | 2.400 |
Why?
| Lower Extremity | 16 | 2022 | 335 | 2.200 |
Why?
| Vascular Surgical Procedures | 21 | 2023 | 262 | 2.100 |
Why?
| General Surgery | 8 | 2024 | 134 | 1.980 |
Why?
| Leg | 14 | 2007 | 234 | 1.630 |
Why?
| Rivaroxaban | 14 | 2022 | 208 | 1.490 |
Why?
| Platelet Aggregation Inhibitors | 14 | 2022 | 402 | 1.490 |
Why?
| Endovascular Procedures | 9 | 2023 | 276 | 1.480 |
Why?
| Peripheral Vascular Diseases | 12 | 2022 | 98 | 1.480 |
Why?
| Limb Salvage | 9 | 2021 | 52 | 1.060 |
Why?
| Surgeons | 4 | 2021 | 243 | 0.990 |
Why?
| Aspirin | 13 | 2022 | 334 | 0.980 |
Why?
| Blood Vessel Prosthesis Implantation | 5 | 2023 | 181 | 0.950 |
Why?
| Femoral Artery | 10 | 2023 | 175 | 0.910 |
Why?
| Arterial Occlusive Diseases | 7 | 2008 | 74 | 0.880 |
Why?
| Education, Medical, Graduate | 5 | 2024 | 399 | 0.850 |
Why?
| Aortic Aneurysm, Abdominal | 3 | 2017 | 118 | 0.780 |
Why?
| Treatment Outcome | 41 | 2023 | 9342 | 0.770 |
Why?
| Popliteal Artery | 7 | 2023 | 59 | 0.740 |
Why?
| Intermittent Claudication | 12 | 2022 | 109 | 0.740 |
Why?
| Puerperal Disorders | 1 | 2020 | 33 | 0.730 |
Why?
| Pregnancy Complications, Cardiovascular | 1 | 2020 | 70 | 0.720 |
Why?
| Risk Factors | 33 | 2023 | 9000 | 0.710 |
Why?
| Career Choice | 3 | 2020 | 192 | 0.700 |
Why?
| Factor Xa Inhibitors | 7 | 2022 | 138 | 0.700 |
Why?
| Personnel Selection | 3 | 2018 | 71 | 0.690 |
Why?
| Vascular System Injuries | 4 | 2021 | 70 | 0.650 |
Why?
| Vascular Patency | 13 | 2023 | 98 | 0.650 |
Why?
| Aged | 45 | 2023 | 19657 | 0.610 |
Why?
| Postoperative Complications | 11 | 2022 | 2235 | 0.590 |
Why?
| Time Factors | 20 | 2022 | 6412 | 0.590 |
Why?
| Risk Assessment | 15 | 2021 | 3057 | 0.570 |
Why?
| Humans | 104 | 2024 | 118974 | 0.570 |
Why?
| Clinical Competence | 4 | 2022 | 951 | 0.560 |
Why?
| Elective Surgical Procedures | 2 | 2017 | 160 | 0.550 |
Why?
| Male | 65 | 2023 | 57801 | 0.550 |
Why?
| Quality Indicators, Health Care | 3 | 2016 | 295 | 0.550 |
Why?
| Female | 63 | 2023 | 61565 | 0.540 |
Why?
| Mentors | 2 | 2020 | 166 | 0.540 |
Why?
| Venous Thromboembolism | 3 | 2023 | 234 | 0.520 |
Why?
| Thrombosis | 4 | 2023 | 309 | 0.500 |
Why?
| Middle Aged | 45 | 2023 | 27617 | 0.490 |
Why?
| Arteriovenous Shunt, Surgical | 2 | 2011 | 16 | 0.480 |
Why?
| Renal Dialysis | 3 | 2013 | 378 | 0.460 |
Why?
| Upper Extremity | 2 | 2011 | 81 | 0.460 |
Why?
| Angioplasty, Balloon | 3 | 2023 | 88 | 0.450 |
Why?
| Retrospective Studies | 26 | 2024 | 12978 | 0.450 |
Why?
| Paclitaxel | 3 | 2021 | 195 | 0.430 |
Why?
| Aged, 80 and over | 20 | 2017 | 6561 | 0.420 |
Why?
| Kidney Failure, Chronic | 4 | 2013 | 516 | 0.390 |
Why?
| Patient Care Management | 1 | 2011 | 57 | 0.390 |
Why?
| Quality of Life | 6 | 2022 | 2366 | 0.380 |
Why?
| Activities of Daily Living | 4 | 2006 | 354 | 0.380 |
Why?
| Alprostadil | 2 | 2007 | 32 | 0.370 |
Why?
| Medicaid | 1 | 2014 | 411 | 0.370 |
Why?
| Incidence | 8 | 2021 | 2424 | 0.360 |
Why?
| Wound Healing | 5 | 2009 | 270 | 0.350 |
Why?
| Patient Readmission | 5 | 2023 | 634 | 0.350 |
Why?
| Medicare | 1 | 2014 | 663 | 0.340 |
Why?
| Continuity of Patient Care | 1 | 2011 | 265 | 0.330 |
Why?
| Drug-Eluting Stents | 2 | 2021 | 66 | 0.320 |
Why?
| Brain Ischemia | 2 | 2022 | 310 | 0.320 |
Why?
| Adult | 30 | 2023 | 31512 | 0.320 |
Why?
| Comorbidity | 7 | 2017 | 1527 | 0.310 |
Why?
| Kidney Diseases | 2 | 2011 | 439 | 0.300 |
Why?
| Critical Illness | 6 | 2020 | 662 | 0.300 |
Why?
| Decision Support Techniques | 2 | 2021 | 364 | 0.300 |
Why?
| Students, Medical | 2 | 2023 | 311 | 0.300 |
Why?
| Neoplasms | 1 | 2021 | 2179 | 0.300 |
Why?
| Ribs | 2 | 2016 | 33 | 0.300 |
Why?
| United States | 15 | 2024 | 12555 | 0.290 |
Why?
| Prodrugs | 1 | 2007 | 44 | 0.290 |
Why?
| Stroke | 3 | 2022 | 1047 | 0.290 |
Why?
| Computer Simulation | 1 | 2011 | 922 | 0.290 |
Why?
| Software | 1 | 2011 | 613 | 0.290 |
Why?
| Coronary Artery Disease | 3 | 2020 | 647 | 0.280 |
Why?
| Atherosclerosis | 2 | 2020 | 345 | 0.280 |
Why?
| Thoracic Outlet Syndrome | 2 | 2016 | 12 | 0.270 |
Why?
| Surveys and Questionnaires | 9 | 2022 | 4708 | 0.270 |
Why?
| Catheterization, Peripheral | 2 | 2009 | 107 | 0.260 |
Why?
| Reoperation | 10 | 2014 | 557 | 0.260 |
Why?
| Femoral Vein | 3 | 2008 | 29 | 0.260 |
Why?
| Graft Occlusion, Vascular | 3 | 2011 | 35 | 0.260 |
Why?
| Cardiovascular Surgical Procedures | 2 | 2001 | 37 | 0.250 |
Why?
| Carotid Stenosis | 2 | 1996 | 75 | 0.250 |
Why?
| Anticoagulants | 4 | 2023 | 559 | 0.240 |
Why?
| Ultrasonography, Doppler | 2 | 2021 | 104 | 0.240 |
Why?
| Fibrinolytic Agents | 3 | 2022 | 238 | 0.240 |
Why?
| Acute Disease | 4 | 2021 | 940 | 0.230 |
Why?
| Chi-Square Distribution | 3 | 2017 | 525 | 0.230 |
Why?
| Drug Therapy, Combination | 6 | 2022 | 965 | 0.230 |
Why?
| Hemorrhage | 6 | 2023 | 623 | 0.230 |
Why?
| Cranial Nerve Injuries | 1 | 2023 | 5 | 0.230 |
Why?
| Carotid Body Tumor | 1 | 2023 | 5 | 0.230 |
Why?
| Diabetes Complications | 3 | 2015 | 218 | 0.220 |
Why?
| Academic Medical Centers | 3 | 2017 | 422 | 0.220 |
Why?
| Fibrin Fibrinogen Degradation Products | 1 | 2023 | 79 | 0.220 |
Why?
| Antifibrinolytic Agents | 1 | 2023 | 44 | 0.220 |
Why?
| Diabetic Foot | 2 | 2019 | 23 | 0.220 |
Why?
| Tibial Arteries | 4 | 2008 | 13 | 0.210 |
Why?
| Meditation | 1 | 2022 | 34 | 0.210 |
Why?
| Thrombolytic Therapy | 1 | 2003 | 118 | 0.210 |
Why?
| Quality Improvement | 2 | 2022 | 963 | 0.200 |
Why?
| Smoking Cessation | 2 | 2002 | 360 | 0.200 |
Why?
| Heparin | 3 | 2023 | 230 | 0.200 |
Why?
| Aortic Aneurysm, Thoracic | 1 | 2023 | 121 | 0.200 |
Why?
| Hemostatic Techniques | 1 | 2001 | 40 | 0.190 |
Why?
| Blood Coagulation Disorders | 1 | 2023 | 208 | 0.190 |
Why?
| Mentoring | 1 | 2022 | 101 | 0.190 |
Why?
| Hospital Departments | 1 | 2020 | 8 | 0.190 |
Why?
| Aortic Diseases | 1 | 2001 | 94 | 0.190 |
Why?
| Specialties, Surgical | 2 | 2017 | 76 | 0.190 |
Why?
| Blood Pressure Determination | 1 | 2021 | 133 | 0.180 |
Why?
| Double-Blind Method | 7 | 2020 | 1687 | 0.180 |
Why?
| Suture Techniques | 1 | 2001 | 134 | 0.180 |
Why?
| Hyperlipidemias | 1 | 2001 | 128 | 0.180 |
Why?
| Forefoot, Human | 1 | 1999 | 6 | 0.180 |
Why?
| Walking | 4 | 2022 | 415 | 0.180 |
Why?
| Databases, Factual | 4 | 2017 | 1231 | 0.180 |
Why?
| Toes | 1 | 1999 | 26 | 0.180 |
Why?
| Multivariate Analysis | 4 | 2019 | 1474 | 0.180 |
Why?
| Logistic Models | 3 | 2017 | 1901 | 0.180 |
Why?
| Aneurysm | 2 | 1997 | 32 | 0.180 |
Why?
| Proportional Hazards Models | 3 | 2021 | 1125 | 0.180 |
Why?
| Counseling | 1 | 2002 | 353 | 0.170 |
Why?
| Self Concept | 1 | 2021 | 215 | 0.170 |
Why?
| Canagliflozin | 1 | 2019 | 11 | 0.170 |
Why?
| Patient Selection | 4 | 2014 | 676 | 0.170 |
Why?
| Clinical Clerkship | 1 | 2020 | 98 | 0.170 |
Why?
| Carotid Artery Diseases | 1 | 2019 | 58 | 0.170 |
Why?
| Chronic Disease | 6 | 2011 | 1636 | 0.170 |
Why?
| Drug Prescriptions | 1 | 2020 | 248 | 0.170 |
Why?
| Exercise Therapy | 2 | 2001 | 355 | 0.170 |
Why?
| Iatrogenic Disease | 1 | 1998 | 49 | 0.160 |
Why?
| School Admission Criteria | 1 | 2018 | 30 | 0.160 |
Why?
| Extremities | 2 | 2009 | 113 | 0.160 |
Why?
| Follow-Up Studies | 9 | 2021 | 4596 | 0.160 |
Why?
| Blood Vessels | 2 | 1998 | 187 | 0.160 |
Why?
| Arm | 2 | 2004 | 106 | 0.160 |
Why?
| Odds Ratio | 3 | 2016 | 996 | 0.160 |
Why?
| Cost of Illness | 1 | 2019 | 258 | 0.160 |
Why?
| Arteriosclerosis | 1 | 1997 | 88 | 0.160 |
Why?
| Physician Executives | 1 | 2017 | 37 | 0.150 |
Why?
| Ultrasonography, Doppler, Duplex | 2 | 1996 | 39 | 0.150 |
Why?
| Myocardial Infarction | 2 | 2022 | 968 | 0.150 |
Why?
| Diabetes Mellitus | 3 | 2021 | 942 | 0.150 |
Why?
| Homocysteine | 1 | 1997 | 137 | 0.150 |
Why?
| Blood Vessel Prosthesis | 2 | 1995 | 115 | 0.150 |
Why?
| Subclavian Artery | 1 | 1997 | 31 | 0.150 |
Why?
| Burnout, Professional | 1 | 2022 | 330 | 0.150 |
Why?
| Tertiary Care Centers | 1 | 2017 | 119 | 0.150 |
Why?
| Vascular Diseases | 2 | 2015 | 241 | 0.150 |
Why?
| Incidental Findings | 1 | 2016 | 80 | 0.140 |
Why?
| Endarterectomy, Carotid | 2 | 2013 | 42 | 0.140 |
Why?
| Vascular Malformations | 1 | 2016 | 47 | 0.140 |
Why?
| Sepsis | 2 | 2016 | 531 | 0.140 |
Why?
| Cardiovascular Diseases | 4 | 2021 | 1798 | 0.140 |
Why?
| Curriculum | 4 | 2024 | 910 | 0.130 |
Why?
| Survival Rate | 4 | 2021 | 1720 | 0.130 |
Why?
| Osteotomy | 1 | 2016 | 158 | 0.130 |
Why?
| Interprofessional Relations | 1 | 2017 | 261 | 0.130 |
Why?
| Popliteal Vein | 1 | 1994 | 4 | 0.130 |
Why?
| Kaplan-Meier Estimate | 4 | 2021 | 842 | 0.130 |
Why?
| Disease Progression | 3 | 2014 | 2490 | 0.130 |
Why?
| Multidetector Computed Tomography | 1 | 2014 | 27 | 0.120 |
Why?
| Hypertension | 2 | 2001 | 1203 | 0.120 |
Why?
| Attitude of Health Personnel | 2 | 2021 | 992 | 0.120 |
Why?
| Multiple Trauma | 1 | 2014 | 97 | 0.120 |
Why?
| Endarterectomy | 1 | 1993 | 6 | 0.120 |
Why?
| Premedication | 1 | 1993 | 40 | 0.120 |
Why?
| Thoracotomy | 1 | 2014 | 84 | 0.120 |
Why?
| Recurrence | 4 | 2014 | 975 | 0.120 |
Why?
| Bandages | 1 | 1993 | 31 | 0.120 |
Why?
| Surgery, Computer-Assisted | 1 | 2014 | 69 | 0.120 |
Why?
| Recovery of Function | 3 | 2011 | 604 | 0.110 |
Why?
| Analgesics, Opioid | 1 | 2020 | 794 | 0.110 |
Why?
| Program Evaluation | 1 | 2017 | 845 | 0.110 |
Why?
| Ulnar Artery | 1 | 1992 | 2 | 0.110 |
Why?
| Ischemic Attack, Transient | 1 | 1993 | 62 | 0.110 |
Why?
| Injury Severity Score | 3 | 2021 | 528 | 0.110 |
Why?
| Research Design | 2 | 2009 | 969 | 0.110 |
Why?
| Life Tables | 3 | 1998 | 17 | 0.110 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 1185 | 0.110 |
Why?
| Stress, Psychological | 1 | 2020 | 972 | 0.110 |
Why?
| Predictive Value of Tests | 4 | 2021 | 1868 | 0.110 |
Why?
| Seasons | 1 | 2014 | 461 | 0.110 |
Why?
| Young Adult | 6 | 2021 | 10793 | 0.110 |
Why?
| Renal Insufficiency | 1 | 2014 | 150 | 0.110 |
Why?
| Fingers | 1 | 1992 | 83 | 0.110 |
Why?
| Radial Artery | 1 | 1992 | 74 | 0.100 |
Why?
| Prognosis | 5 | 2021 | 3443 | 0.100 |
Why?
| Research Personnel | 1 | 2013 | 158 | 0.100 |
Why?
| Thrombectomy | 2 | 2003 | 60 | 0.100 |
Why?
| Aorta, Thoracic | 1 | 2014 | 248 | 0.100 |
Why?
| Oregon | 1 | 2011 | 69 | 0.100 |
Why?
| Hypoglycemic Agents | 1 | 2019 | 1032 | 0.100 |
Why?
| Efficiency | 1 | 2011 | 89 | 0.090 |
Why?
| Adolescent | 7 | 2023 | 18480 | 0.090 |
Why?
| Fellowships and Scholarships | 1 | 2013 | 250 | 0.090 |
Why?
| Workload | 1 | 2011 | 128 | 0.090 |
Why?
| Reproducibility of Results | 3 | 2021 | 2874 | 0.090 |
Why?
| Arteries | 2 | 2022 | 250 | 0.090 |
Why?
| Catheterization | 2 | 2003 | 163 | 0.090 |
Why?
| Controlled Clinical Trials as Topic | 1 | 2009 | 26 | 0.090 |
Why?
| Device Approval | 1 | 2009 | 21 | 0.090 |
Why?
| Safety | 1 | 2011 | 304 | 0.090 |
Why?
| Disability Evaluation | 1 | 2011 | 280 | 0.090 |
Why?
| Coated Materials, Biocompatible | 2 | 2023 | 58 | 0.090 |
Why?
| Skin | 1 | 1993 | 657 | 0.080 |
Why?
| Axillary Vein | 1 | 2008 | 2 | 0.080 |
Why?
| Global Health | 2 | 2021 | 310 | 0.080 |
Why?
| Saphenous Vein | 3 | 1998 | 32 | 0.080 |
Why?
| Pregnancy | 1 | 2020 | 5691 | 0.080 |
Why?
| Athletic Injuries | 1 | 2014 | 495 | 0.080 |
Why?
| Colorado | 3 | 2016 | 4196 | 0.080 |
Why?
| Prevalence | 1 | 2014 | 2326 | 0.080 |
Why?
| Dose-Response Relationship, Drug | 3 | 2021 | 1945 | 0.080 |
Why?
| Radiography | 4 | 2015 | 861 | 0.080 |
Why?
| Biomedical Research | 1 | 2013 | 612 | 0.080 |
Why?
| Practice Guidelines as Topic | 2 | 2011 | 1440 | 0.080 |
Why?
| Antineoplastic Agents, Phytogenic | 2 | 2021 | 180 | 0.080 |
Why?
| Brachial Artery | 1 | 2008 | 181 | 0.080 |
Why?
| Family Practice | 2 | 2020 | 438 | 0.080 |
Why?
| Patient Care Team | 1 | 2011 | 521 | 0.070 |
Why?
| Prospective Studies | 5 | 2021 | 6471 | 0.070 |
Why?
| Iloprost | 1 | 2006 | 46 | 0.070 |
Why?
| Chemotherapy, Adjuvant | 1 | 2007 | 360 | 0.070 |
Why?
| United States Department of Veterans Affairs | 1 | 2009 | 555 | 0.070 |
Why?
| Exercise Test | 3 | 2011 | 551 | 0.070 |
Why?
| Regional Blood Flow | 2 | 1999 | 418 | 0.070 |
Why?
| Carotid Artery, Internal | 2 | 1996 | 34 | 0.070 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2019 | 2174 | 0.070 |
Why?
| Sulfonic Acids | 1 | 2004 | 13 | 0.060 |
Why?
| Randomized Controlled Trials as Topic | 2 | 2020 | 1244 | 0.060 |
Why?
| Single-Blind Method | 2 | 2015 | 269 | 0.060 |
Why?
| Acetates | 1 | 2004 | 98 | 0.060 |
Why?
| Veins | 2 | 1995 | 60 | 0.060 |
Why?
| Specialty Boards | 1 | 2024 | 39 | 0.060 |
Why?
| Clinical Trials as Topic | 1 | 2008 | 969 | 0.060 |
Why?
| Thromboplastin | 1 | 2023 | 68 | 0.060 |
Why?
| Blood Pressure | 2 | 2021 | 1664 | 0.060 |
Why?
| Atherectomy | 1 | 2023 | 33 | 0.060 |
Why?
| Sexism | 1 | 2023 | 45 | 0.060 |
Why?
| Forecasting | 2 | 2001 | 353 | 0.060 |
Why?
| Physical Exertion | 1 | 2004 | 222 | 0.060 |
Why?
| Survival Analysis | 2 | 2004 | 1267 | 0.050 |
Why?
| Societies, Medical | 2 | 2009 | 703 | 0.050 |
Why?
| Mass Screening | 1 | 2009 | 1052 | 0.050 |
Why?
| Psychomotor Performance | 1 | 2004 | 290 | 0.050 |
Why?
| Numbers Needed To Treat | 1 | 2021 | 8 | 0.050 |
Why?
| Morbidity | 1 | 2023 | 296 | 0.050 |
Why?
| Mobility Limitation | 1 | 2022 | 62 | 0.050 |
Why?
| Hemangioendothelioma, Epithelioid | 1 | 2001 | 5 | 0.050 |
Why?
| Vascular Neoplasms | 1 | 2001 | 16 | 0.050 |
Why?
| Oxygen Consumption | 1 | 2004 | 586 | 0.050 |
Why?
| Educational Measurement | 1 | 2024 | 289 | 0.050 |
Why?
| Angioplasty | 1 | 2001 | 39 | 0.050 |
Why?
| Cadaver | 1 | 2022 | 327 | 0.050 |
Why?
| Heart Failure | 1 | 2014 | 1969 | 0.050 |
Why?
| Artificial Limbs | 1 | 2003 | 116 | 0.050 |
Why?
| Tetrazoles | 1 | 2001 | 32 | 0.050 |
Why?
| Habits | 1 | 2020 | 38 | 0.050 |
Why?
| Aneurysm, False | 1 | 2001 | 46 | 0.050 |
Why?
| Enzyme Inhibitors | 1 | 2004 | 827 | 0.050 |
Why?
| Empathy | 1 | 2022 | 142 | 0.050 |
Why?
| Equipment Failure | 1 | 2001 | 114 | 0.050 |
Why?
| Arterial Pressure | 1 | 2021 | 99 | 0.050 |
Why?
| Joint Dislocations | 1 | 2021 | 59 | 0.050 |
Why?
| Physician's Role | 1 | 2002 | 200 | 0.050 |
Why?
| Angiography | 1 | 2001 | 185 | 0.050 |
Why?
| Radiography, Interventional | 1 | 2001 | 113 | 0.050 |
Why?
| Severity of Illness Index | 2 | 2008 | 2674 | 0.050 |
Why?
| Internal Medicine | 1 | 2002 | 215 | 0.050 |
Why?
| Diagnostic Imaging | 3 | 2007 | 294 | 0.050 |
Why?
| Internationality | 1 | 2020 | 152 | 0.050 |
Why?
| Pulse | 1 | 1999 | 27 | 0.040 |
Why?
| Toe Joint | 1 | 1999 | 11 | 0.040 |
Why?
| Proprotein Convertase 9 | 1 | 2020 | 60 | 0.040 |
Why?
| Knee Injuries | 1 | 2021 | 103 | 0.040 |
Why?
| Pulsatile Flow | 1 | 1999 | 54 | 0.040 |
Why?
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2001 | 195 | 0.040 |
Why?
| Debridement | 1 | 1999 | 79 | 0.040 |
Why?
| Metatarsal Bones | 1 | 1999 | 47 | 0.040 |
Why?
| Pain, Postoperative | 1 | 2020 | 211 | 0.040 |
Why?
| Myocardial Revascularization | 1 | 2019 | 72 | 0.040 |
Why?
| Arteriovenous Fistula | 1 | 1998 | 29 | 0.040 |
Why?
| Iliac Aneurysm | 1 | 1998 | 13 | 0.040 |
Why?
| Catheters, Indwelling | 1 | 1998 | 81 | 0.040 |
Why?
| Postoperative Care | 1 | 2019 | 237 | 0.040 |
Why?
| Knee Joint | 1 | 2021 | 353 | 0.040 |
Why?
| Intraoperative Complications | 1 | 1998 | 132 | 0.040 |
Why?
| Purinergic P2Y Receptor Antagonists | 1 | 2018 | 62 | 0.040 |
Why?
| Carotid Arteries | 1 | 2019 | 184 | 0.040 |
Why?
| Antiviral Agents | 1 | 2023 | 654 | 0.040 |
Why?
| Coronary Disease | 1 | 2000 | 356 | 0.040 |
Why?
| Diagnosis, Differential | 2 | 2014 | 1384 | 0.040 |
Why?
| Combined Modality Therapy | 1 | 2020 | 1166 | 0.040 |
Why?
| Age Factors | 1 | 2004 | 2995 | 0.040 |
Why?
| Neck | 1 | 1997 | 89 | 0.040 |
Why?
| Administration, Oral | 1 | 2019 | 756 | 0.040 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2001 | 387 | 0.040 |
Why?
| Blood Loss, Surgical | 1 | 2016 | 87 | 0.040 |
Why?
| Health Promotion | 1 | 2022 | 691 | 0.030 |
Why?
| Cardiology | 1 | 2019 | 272 | 0.030 |
Why?
| Postoperative Hemorrhage | 1 | 2016 | 79 | 0.030 |
Why?
| Risk | 1 | 2019 | 853 | 0.030 |
Why?
| Risk Management | 2 | 2007 | 90 | 0.030 |
Why?
| Fractures, Bone | 1 | 2021 | 380 | 0.030 |
Why?
| Foot | 1 | 1996 | 106 | 0.030 |
Why?
| Pain Measurement | 2 | 2009 | 469 | 0.030 |
Why?
| Aortic Rupture | 1 | 1995 | 26 | 0.030 |
Why?
| Aorta, Abdominal | 1 | 1995 | 40 | 0.030 |
Why?
| Vaccination | 1 | 2023 | 1222 | 0.030 |
Why?
| Groin | 1 | 1994 | 17 | 0.030 |
Why?
| Glasgow Coma Scale | 1 | 2014 | 150 | 0.030 |
Why?
| Exercise | 1 | 2004 | 1657 | 0.030 |
Why?
| Carotid Artery, External | 1 | 1993 | 2 | 0.030 |
Why?
| Orthopedic Equipment | 1 | 1993 | 5 | 0.030 |
Why?
| Venous Insufficiency | 1 | 1993 | 11 | 0.030 |
Why?
| Operative Time | 1 | 2014 | 114 | 0.030 |
Why?
| Cerebral Revascularization | 1 | 1993 | 15 | 0.030 |
Why?
| Tomography, X-Ray Computed | 2 | 2016 | 2436 | 0.030 |
Why?
| Prosthesis Failure | 1 | 1994 | 120 | 0.030 |
Why?
| Carotid Artery, Common | 1 | 1993 | 30 | 0.030 |
Why?
| Cerebral Angiography | 1 | 1993 | 116 | 0.030 |
Why?
| Ankle | 1 | 1993 | 71 | 0.030 |
Why?
| Surgical Wound Infection | 1 | 2016 | 251 | 0.030 |
Why?
| Longitudinal Studies | 2 | 1999 | 2513 | 0.030 |
Why?
| Arteritis | 1 | 1993 | 27 | 0.030 |
Why?
| Pressure | 1 | 1993 | 226 | 0.030 |
Why?
| Housing | 1 | 1993 | 123 | 0.030 |
Why?
| Inflammation | 1 | 2023 | 2566 | 0.030 |
Why?
| Nursing Homes | 1 | 1993 | 130 | 0.030 |
Why?
| Practice Patterns, Physicians' | 1 | 2020 | 1200 | 0.030 |
Why?
| Cohort Studies | 1 | 2022 | 5116 | 0.030 |
Why?
| Lung | 1 | 2004 | 3664 | 0.020 |
Why?
| Sickness Impact Profile | 1 | 2011 | 51 | 0.020 |
Why?
| Pain | 2 | 2009 | 735 | 0.020 |
Why?
| Child | 2 | 2020 | 19129 | 0.020 |
Why?
| Cross-Sectional Studies | 1 | 2021 | 4552 | 0.020 |
Why?
| Hospitalization | 1 | 1999 | 1785 | 0.020 |
Why?
| Pneumonia | 1 | 2016 | 592 | 0.020 |
Why?
| Anti-Bacterial Agents | 1 | 1999 | 1510 | 0.020 |
Why?
| Equipment Safety | 1 | 2009 | 38 | 0.020 |
Why?
| Length of Stay | 1 | 2014 | 1032 | 0.020 |
Why?
| Ligation | 1 | 2008 | 82 | 0.020 |
Why?
| Illinois | 1 | 2008 | 38 | 0.020 |
Why?
| Tissue and Organ Harvesting | 1 | 2008 | 67 | 0.020 |
Why?
| Cardiovascular Agents | 1 | 2009 | 126 | 0.020 |
Why?
| Equipment Design | 1 | 2009 | 519 | 0.020 |
Why?
| Smoking | 1 | 2015 | 1487 | 0.020 |
Why?
| Magnetic Resonance Angiography | 1 | 2009 | 210 | 0.020 |
Why?
| Constriction, Pathologic | 1 | 2008 | 203 | 0.020 |
Why?
| Ulcer | 1 | 2007 | 28 | 0.020 |
Why?
| Cerebral Arterial Diseases | 1 | 2007 | 43 | 0.020 |
Why?
| Registries | 1 | 2014 | 1810 | 0.020 |
Why?
| Evidence-Based Medicine | 1 | 2009 | 693 | 0.020 |
Why?
| Infusions, Intravenous | 1 | 2006 | 380 | 0.020 |
Why?
| Drug Carriers | 1 | 2006 | 119 | 0.020 |
Why?
| Sterol O-Acyltransferase | 1 | 2004 | 4 | 0.020 |
Why?
| Acetamides | 1 | 2004 | 26 | 0.020 |
Why?
| Hemodynamics | 1 | 2009 | 1004 | 0.020 |
Why?
| Reference Values | 1 | 2006 | 774 | 0.020 |
Why?
| Cost-Benefit Analysis | 1 | 2007 | 554 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2006 | 736 | 0.010 |
Why?
| Hyperemia | 1 | 2004 | 43 | 0.010 |
Why?
| Blood Flow Velocity | 1 | 2004 | 327 | 0.010 |
Why?
| Lipids | 1 | 2006 | 607 | 0.010 |
Why?
| Ultrasonography | 1 | 2006 | 716 | 0.010 |
Why?
| Sulfonamides | 1 | 2004 | 445 | 0.010 |
Why?
| World Health Organization | 1 | 2000 | 107 | 0.010 |
Why?
| Costs and Cost Analysis | 1 | 2000 | 202 | 0.010 |
Why?
| Heart Function Tests | 1 | 2000 | 61 | 0.010 |
Why?
| Algorithms | 1 | 2007 | 1541 | 0.010 |
Why?
| Aneurysm, Ruptured | 1 | 1998 | 38 | 0.010 |
Why?
| Epoprostenol | 1 | 1999 | 132 | 0.010 |
Why?
| Preoperative Care | 1 | 2000 | 332 | 0.010 |
Why?
| Gangrene | 1 | 1996 | 6 | 0.010 |
Why?
| Patient Satisfaction | 1 | 2000 | 610 | 0.010 |
Why?
| Models, Theoretical | 1 | 2000 | 556 | 0.010 |
Why?
| Embolization, Therapeutic | 1 | 1998 | 192 | 0.010 |
Why?
| Ultrasonography, Doppler, Color | 1 | 1995 | 35 | 0.010 |
Why?
| Health Status | 1 | 2000 | 726 | 0.010 |
Why?
| Stents | 1 | 1998 | 457 | 0.010 |
Why?
| Takayasu Arteritis | 1 | 1993 | 8 | 0.010 |
Why?
| Behcet Syndrome | 1 | 1993 | 17 | 0.010 |
Why?
| Infant, Newborn | 1 | 1999 | 5255 | 0.000 |
Why?
|
|
Nehler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|